Stay updated with the latest thrombosis-prevention news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on thrombosis-prevention topics.
New Delhi, Oct 1 (PTI) Drug maker Lupin on Wednesday said it has launched an anticoagulant medication in the US. The company has launched Rivaroxaban for Oral Suspension (1 mg/mL), a generic version of Janssen Pharmaceuticals, Inc.'s Xarelto for Oral Suspension, in the US, the drug maker said in a statement. Rivaroxaban for Oral Suspension is indicated for the treatment of venous thromboembolism (VTE) and the reduction in the risk of recurrent VTE in pediatric patients. It is also indicated f ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.